rs72653170
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 15P and 4B. PM1PP2PP3_StrongPP5_Very_StrongBS2
The NM_000088.4(COL1A1):c.3040C>T(p.Arg1014Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000551 in 1,451,640 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1014H) has been classified as Uncertain significance.
Frequency
Consequence
NM_000088.4 missense
Scores
Clinical Significance
Conservation
Publications
- Caffey diseaseInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen
- combined osteogenesis imperfecta and Ehlers-Danlos syndrome 1Inheritance: AD Classification: DEFINITIVE, MODERATE Submitted by: Ambry Genetics, ClinGen
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, arthrochalasia typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia, G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
- osteogenesis imperfecta type 1Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- osteogenesis imperfecta type 2Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- osteogenesis imperfecta type 3Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
- osteogenesis imperfecta type 4Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet, ClinGen
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: MODERATE Submitted by: ClinGen
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ehlers-Danlos/osteogenesis imperfecta syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- high bone mass osteogenesis imperfectaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL1A1 | NM_000088.4 | c.3040C>T | p.Arg1014Cys | missense_variant | Exon 41 of 51 | ENST00000225964.10 | NP_000079.2 | |
| COL1A1 | XM_011524341.2 | c.2842C>T | p.Arg948Cys | missense_variant | Exon 38 of 48 | XP_011522643.1 | ||
| COL1A1 | XM_005257058.5 | c.2770C>T | p.Arg924Cys | missense_variant | Exon 39 of 49 | XP_005257115.2 | ||
| COL1A1 | XM_005257059.5 | c.2122C>T | p.Arg708Cys | missense_variant | Exon 28 of 38 | XP_005257116.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000799 AC: 2AN: 250334 AF XY: 0.00000738 show subpopulations
GnomAD4 exome AF: 0.00000551 AC: 8AN: 1451640Hom.: 0 Cov.: 33 AF XY: 0.00000277 AC XY: 2AN XY: 722746 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Infantile cortical hyperostosis Pathogenic:2Other:1
This variant changes an arginine residue in the collagen type I alpha 1 chain to a cysteine residue. The variant is very rare in the gnomAD database and is predicted to be damaging to protein function (Revel 0.93. We have observed this variant in our in-house molecular diagnosis laboratory in several families with Caffey’s disease. The variant is a typical cause of Caffey’s disease and has been published in several reports (e.g., PMID 15864348). -
- -
- -
not provided Pathogenic:2
The COL1A1 c.3040C>T; p.Arg1014Cys variant (rs72653170) is reported in the literature in numerous individuals and families affected with infantile cortical hyperostosis, also called Caffey disease (Cho 2008, Gensure 2005, Kitaoka 2014, Suphapeetiporn 2007). This variant has been observed to segregate with disease in multiple families, although it exhibits incomplete penetrance (Gensure 2005, Kitaoka 2014, Suphapeetiporn 2007). In one family, the variant was found in two affected identical twins but was absent from both parents, suggesting a de novo origin (Gensure 2005). This variant is found on only two chromosomes in the Genome Aggregation Database (2/250334 alleles), indicating it is not a common polymorphism. The arginine at codon 1014 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. Based on available information, this variant is considered to be pathogenic. References: Cho TJ et al. The c.3040C > T mutation in COL1A1 is recurrent in Korean patients with infantile cortical hyperostosis (Caffey disease). J Hum Genet. 2008;53(10):947. Gensure RC et al. A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders. J Clin Invest. 2005 May;115(5):1250-7. Kitaoka T et al. Two Japanese familial cases of Caffey disease with and without the common COL1A1 mutation and normal bone density, and review of the literature. Eur J Pediatr. 2014 Jun;173(6):799-804. Suphapeetiporn K et al. Expanding the phenotypic spectrum of Caffey disease. Clin Genet. 2007 Mar;71(3):280-4. -
Skin biopsy from an affected adult with this variant demonstrated less densely packed collagen fibrils of variable shape and size surrounded by granular material, while analysis of collagen fibrils in cultured skin fibroblasts indicated increased disulfide crosslinking (Gensure et al., 2005); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Located in the Gly-X-Y triple helical region of the pro-alpha1(I) chain encoded by the COL1A1 gene, where triplet glycine substitutions are the most common cause of osteogenesis imperfecta (OI). The effect of missense substitution at the X and Y positions are more difficult to predict; however, multiple variants that result in introduction of a Cys residue in pro-alpha1(I) have been reported to be pathogenic (Dalgleish, 1998); This variant is associated with the following publications: (PMID: 21249479, 22855962, 15864348, 18553566, 18704262, 17309652, 21567126, 24390061) -
Infantile cortical hyperostosis;C0023931:Osteogenesis imperfecta type I;C0029458:Postmenopausal osteoporosis;C0268358:Osteogenesis imperfecta, perinatal lethal;C0268362:Osteogenesis imperfecta type III;C0268363:Osteogenesis imperfecta with normal sclerae, dominant form;C4551623:Ehlers-Danlos syndrome, arthrochalasia type Pathogenic:1
- -
Osteogenesis imperfecta type I Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 1014 of the COL1A1 protein (p.Arg1014Cys). This variant is present in population databases (rs72653170, gnomAD 0.006%). This missense change has been observed in individual(s) with Caffey disease (PMID: 15864348, 17309652, 18553566, 18704262, 21249479, 21567126, 24390061). It has also been observed to segregate with disease in related individuals. This variant is also known as p.Arg836Cys. ClinVar contains an entry for this variant (Variation ID: 17347). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt COL1A1 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects COL1A1 function (PMID: 15864348). For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at